Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: Neurex Corporation

No earlier versions found for this Subject.

Return to Neurex Corporation

I have been in this stock for the past year and a half and have seen this move from 3 to 25 and now at 15 with a support aroung 13. I hear that it has 2 drugs in Phase 3 trials and soon (Jan/Feb 97), the FDA will disposition on its drug Coropalm with the second one expected at the end of 1997. I hear that to date the Phase 3 trials have shown great promise and Crutendden Roth and a Biotech newsletter out of NH have placed this stock to move to 40 by mid 1997.

This board are for the followers of Neurex in Menlo Park, CA.